Literature DB >> 17266553

Regulation of HIV-1 transcription by protein phosphatase 1.

Sergei Nekhai1, Marina Jerebtsova, Angela Jackson, William Southerland.   

Abstract

The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new drugs. Targeting host cell factors involved in the regulation of HIV-1 replication might be one way to overcome the resistance of HIV-1 to anti-viral agents. Our recent studies identified protein phosphatase-1 (PP1) as an important regulator of HIV-1 transcription. Transcription of HIV-1 genes is activated by HIV-1 Tat protein that induces phosphorylation of the C-terminal domain of RNA polymerase-II by CDK9/cyclin T1. We have shown that HIV-1 Tat binds PP1 in vitro; targets PP1 to the nucleus; and that Tat interaction with PP1 is important for HIV-1 transcription. In this review, we discuss two potential targets of PP1 in Tat-induced HIV-1 transcription: the C-terminal domain of RNA polymerase-II and CDK9. We also present a computer model of Tat-PP1 complex that might be useful for future drug design in anti-HIV-1 therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266553     DOI: 10.2174/157016207779316279

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  20 in total

Review 1.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

2.  Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease.

Authors:  Namita Kumari; Tatiana Ammosova; Sharmin Diaz; Xionghao Lin; Xiaomei Niu; Andrey Ivanov; Marina Jerebtsova; Subhash Dhawan; Patricia Oneal; Sergei Nekhai
Journal:  Blood Adv       Date:  2016-12-27

3.  Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia.

Authors:  Thirunavukkarasu Velusamy; Nallasivam Palanisamy; Shanker Kalyana-Sundaram; Anagh Anant Sahasrabuddhe; Christopher A Maher; Daniel R Robinson; David W Bahler; Timothy T Cornell; Thomas E Wilson; Megan S Lim; Arul M Chinnaiyan; Kojo S J Elenitoba-Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

4.  Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.

Authors:  Upal Roy; Scott A Simpson; Debasis Mondal; Sandra Eloby-Childress; Elsa L Winsor; Mark A Beilke
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

5.  Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells.

Authors:  Sylvie Rato; Sara Maia; Paula M Brito; Leonor Resende; Carina F Pereira; Catarina Moita; Rui P Freitas; José Moniz-Pereira; Nir Hacohen; Luis Ferreira Moita; Joao Goncalves
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

6.  Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells.

Authors:  Nayoung Kim; Sami Kukkonen; Sumeet Gupta; Anna Aldovini
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

7.  Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity.

Authors:  Ling Wang; Juan Zhao; Junping Ren; Kenton H Hall; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  Eur J Immunol       Date:  2016-08-29       Impact factor: 5.532

8.  Role of cellular iron and oxygen in the regulation of HIV-1 infection.

Authors:  Sergei Nekhai; Namita Kumari; Subhash Dhawan
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

9.  Protein Phosphatase-1 regulates Rift Valley fever virus replication.

Authors:  Alan Baer; Nazly Shafagati; Ashwini Benedict; Tatiana Ammosova; Andrey Ivanov; Ramin M Hakami; Kaori Terasaki; Shinji Makino; Sergei Nekhai; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2016-01-20       Impact factor: 5.970

10.  Iron chelators ICL670 and 311 inhibit HIV-1 transcription.

Authors:  Zufan Debebe; Tatyana Ammosova; Marina Jerebtsova; Joseph Kurantsin-Mills; Xiaomei Niu; Sharroya Charles; Des R Richardson; Patricio E Ray; Victor R Gordeuk; Sergei Nekhai
Journal:  Virology       Date:  2007-07-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.